Cleared Traditional

K931384 - AVE ALLIANCE DILATATION CATHETER

K931384 is an FDA 510(k) clearance for AVE ALLIANCE DILATATION CATHETER, manufactured by Applied Vascular Engineering, Inc.. The device is a Class 2 Cardiovascular device with product code LIT cleared through the Traditional 510(k) pathway after a 183-day FDA review.

K931384 · Applied Vascular Engineering, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1993
Decision
183d
Days
Class 2
Risk

K931384 is an FDA 510(k) clearance for the AVE ALLIANCE DILATATION CATHETER. Classified as Catheter, Angioplasty, Peripheral, Transluminal (product code LIT), Class II - Special Controls.

Submitted by Applied Vascular Engineering, Inc. (Santa Rosa, US). The FDA issued a Cleared decision on September 17, 1993 after a review of 183 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Applied Vascular Engineering, Inc. devices

FDA 510(k) Submission Details - K931384

510(k) Number K931384 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 18, 1993
Decision Date September 17, 1993
Days to Decision 183 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
58d slower than avg
Panel avg: 125d · This submission: 183d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LIT Device Classification - Class 2, Special Controls

Product Code LIT Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 367
Devices cleared under the same product code (LIT) and FDA review panel - the closest regulatory comparables to K931384.
MEADOX SURGIMED DISPOSABLE PRESSURE GUAGE FOR USE WITH THE OLBERT CATHETER SYSTEM
K933975 · Meadox Medicals, Div. Boston Scientific Corp. · Oct 1993
MEADOX SURGIMED BALLOON CATHETER
K923947 · Meadox Medicals, Div. Boston Scientific Corp. · Sep 1993
OPTI-PLAST 5F PTA CATHETERS
K933483 · Vas-Cath, Inc. · Sep 1993
SCIMED VIPER
K933183 · Scimed Life Systems, Inc. · Sep 1993
SCHNEIDER MATCH-35 PERCUTANEOUS TRANSLUMINAL ANGIO
K926271 · Schneider Intl., Ltd. · Jun 1993
MEADOX(R) SURGIMED OLBERT CATHETER SYSTEM(R)
K921706 · Meadox Medicals, Div. Boston Scientific Corp. · May 1993